Nisa Investment Advisors
ABEO icon

Nisa Investment Advisors’s Abeona Therapeutics ABEO Stock Holding History

Nisa Investment Advisors’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-79
Closed -$2 – 2139
2021
Q3 		$2 Hold
79
– – ﹤0.01% 2286
2021
Q2 		$3 Hold
79
– – ﹤0.01% 2291
2021
Q1 		$4 Hold
79
– – ﹤0.01% 2262
2020
Q4 		$3K Hold
79
– – ﹤0.01% 2276
2020
Q3 		$2K Buy
79
+27
+52% +$1.7K ﹤0.01% 2231
2020
Q2 		$4K Hold
52
– – ﹤0.01% 2016
2020
Q1 		$3K Buy
+52
New +$3.47K ﹤0.01% 1995
2019
Q3 		– Sell
-800
Closed -$96K – 2009
2019
Q2 		$96K Sell
800
-708
-47% -$119K ﹤0.01% 1424
2019
Q1 		$277K Buy
1,508
+400
+36% +$71.5K ﹤0.01% 1218
2018
Q4 		$198K Buy
+1,108
New +$242K ﹤0.01% 1243

Other funds holding ABEO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nisa Investment Advisors's ABEO Position: Q4 2021 in Review

Nisa Investment Advisors sold out of Abeona Therapeutics (ABEO) in Q4 2021, closing a stake of 79 shares — an estimated $2 sold.

Nisa Investment Advisors first reported a position in ABEO in Q4 2018 and held it in 10 quarters. The position peaked at $277K in Q1 2019. 52 funds tracked by Wall St. Rank hold ABEO as of Q4 2021.

  • Nisa Investment Advisors reported no remaining Abeona Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Nisa Investment Advisors sold 79 Abeona Therapeutics shares in Q4 2021, an estimated $2.
  • Nisa Investment Advisors first reported a position in Abeona Therapeutics in Q4 2018 and held it in 10 quarters.
  • Nisa Investment Advisors's Abeona Therapeutics position peaked at $277K in Q1 2019.
  • 52 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2021.

Based on Nisa Investment Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.